2m 2m 2m 2m 2m 2m 2m
CURANEX PHARMA (CURX)
NASDAQ
$5.77+$0.11 (+1.94%)
Price as of Nov 11, 2026 7:56 PM EST- $8.9MMarket Cap
- -50.86%1-Year Change
- BiotechnologyIndustry
CURANEX PHARMA (CURX)
$5.77+$0.11 (+1.94%)
CURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.66 | ||
Change | -$0.43 (-7.06%) | ||
Open | $5.64 | ||
High | $5.86 | ||
Low | $5.52 | ||
Previous Close | $6.09 | ||
Volume | 2,946 | ||
30-Day Average Volume | 10,123 | ||
1-Week Change | -2.41% | ||
1-Month Change | 6.59% | ||
1-Year Change | -50.86% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.6M | ||
Total Assets | $5.1M | ||
Market Cap | $8.9M | ||
Enterprise Value | $5.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.1M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $4.7M | ||
EPS | -$2.40 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 08/20/2026 | ||
Earnings & Revenue